Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Acute Neurotoxicity during ALL Therapy Is Associated with Treatment Intensity, Age and Female Sex - an Analysis of SAE Reports from the UKALL 2003 Trial

Qurat-ul-Ain Wahid, Lina Hamadeh, Sheena McGowan, Rachael Hough, MD BMBS, FRCP, FRCPath, Ajay Vora, MD, Anthony V. Moorman, PhD, Christina Halsey, MD PhD

Blood (2018) 132 (Supplement 1): 1379.

https://doi.org/10.1182/blood-2018-99-113267

Published: 2018

Journal Articles

Dose-Dense Chemoimmunotherapy Including Early CNS Prophylaxis for High-Risk DLBCL. -Final Analysis from a Nordic Phase II Study (the CHIC trial)

Blood (2016) 128 (22): 1854.

https://doi.org/10.1182/blood.V128.22.1854.1854

Published: 2016

Journal Articles

Incidence of Neurological Complications Secondary to Intrathecal Chemotherapy Used As Either Prophylaxis or Treatment of Leptomeningeal Carcinomatosis

Diana M Byrnes, MD MPH, Christopher R Dermarkarian, BS, Ryan Kahn, BA, MHS, Deukwoo Kwon, PhD, Fernando Vargas, MD, Judith Hurley, MD, Justin M. Watts, MD, Jonathan H. Schatz, MD, Ronan T Swords, MD PhD FRCPI, FRCPath

Blood (2016) 128 (22): 5973.

https://doi.org/10.1182/blood.V128.22.5973.5973

Published: 2016

Journal Articles

Flow Cytometric Detection of Liposomes in the CSF of Patients with NHL/ALL, Treated with Intrathecal Liposomal Cytarabine: Synonymous of Toxicity?

Francisco Javier Peñalver, Martínez-Barranco Pilar, Lucía Villalón, MD, Manuel Barón, L Martín, Pilar Ricard, Karmele Arribalzaga, María José Garcia Bueno, Alberto Orfao, MD PhD

Blood (2014) 124 (21): 5444.

https://doi.org/10.1182/blood.V124.21.5444.5444

Published: 2014

Journal Articles

Dose-Dense Chemoimmunotherapy and Early Central Nervous System Prophylaxis For High-Risk Diffuse Large B-Cell Lymphoma. –Preliminary Results From a Nordic Phase II Study

Sirpa Leppa, Anne Maria Tierens, Judit Jorgensen, Mats Jerkeman, Magnus Bjorkholm, PhD, Øystein Fluge, Sirkku Jyrkkio, Harald Holte, MD, PhD

Blood (2013) 122 (21): 849.

https://doi.org/10.1182/blood.V122.21.849.849

Published: 2013

Journal Articles

A Systematic Review on the Use of Intrathecal Rituximab in CNS Lymphoma

Ahraaz Wyne, MD, Leslie Skeith, MD, Joy E. Mangel, MD, FRCPC, Anargyros Xenocostas, MD, FRCPC, Alejandro Lazo-Langner, MD, MSc

Blood (2011) 118 (21): 4987.

https://doi.org/10.1182/blood.V118.21.4987.4987

Published: 2011

Journal Articles

Liposomal Cytarabine (DepoCyte®) for the Prophylaxis and Treatment of Central Nervous System Involvement In Adult Acute Lymphoblastic Leukemia (ALL) - A Retrospective Analysis

Beata Piatkowska-Jakubas, Wojciech Jurczak, Sebastian Giebel, Aleksandra Holowiecka-Goral, Maria Adamczyk-Cioch, Jaroslaw Piszcz

Blood (2010) 116 (21): 2122.

https://doi.org/10.1182/blood.V116.21.2122.2122

Published: 2010

Journal Articles

Efficacy and Safety of Liposomal Cytarabine as Intrathecal Prophylaxis in Patients with Diffuse Large B Cell Lymphoma at High Risk of CNS Involvement: A Multicentric Study Including 80 Patients in Spain.

Adolfo de la Fuente, Sr., Antonio Salar, MD, PhD, Carlos Panizo, MD, Belen Navarro, Sr., Teresa Olave, María Jesus Peñarrubia, MD, JoaquÃn Herrero, MD, PhD, Jose Francisco Tomas, Miguel Canales, Eva González-Barca

Blood (2009) 114 (22): 1663.

https://doi.org/10.1182/blood.V114.22.1663.1663

Published: 2009

Journal Articles

Intrathecal Liposomal Cytarabine (DepoCyte®) for Treatment of Leptomeningeal Involvement From Transformed (Richter's syndrome) and Non-Transformed B-Cell Chronic Lymphocytic Leukemia (B-CLL) in Spain: Report of 8 Cases.

Jose Manuel Calvo-Villas, MD, Jose Antonio Fernández, MD, Rosa Fernández, MD, Ignacio de la Fuente, MD, Ana Cristina Godoy, MD, Rodrigo Martino, MD, Maria del Carmen Mateos, MD, Concepción Poderos, MD

Blood (2009) 114 (22): 4411.

https://doi.org/10.1182/blood.V114.22.4411.4411

Published: 2009

Journal Articles

Safety of Liposomal Cytarabine (DepoCyte ® ) in the Central Nervous System (CNS) Prophylaxis of Patients with Non-Hodgkin’s Lymphoma (NHL) and Acute Lymphoblastic Leukaemia: Results of a Single-Centre Experience

Fabio Ardizzone, Luciano Vitali, Michele Sciacca, Paola Migliora, Cristina Ravanelli, Alberto Santagostino

Blood (2008) 112 (11): 4961.

https://doi.org/10.1182/blood.V112.11.4961.4961

Published: 2008

Journal Articles

Safety of Intrathecal Liposomal Cytarabine (Depocyte®) Injection Given Prophylactically in Patients with High-Risk Diffuse Large B-Cell Lymphoma: A Report of 22 Patients in Spain.

Miguel A. Canales, A. Salar, J.A. Diaz, J.J. Ferreiro, S. Ferrer, A. Llorente, D. Caballero, J.A. Garcia-Marco, L. Palomera, J.J. Sanchez-Blanco, E. Gonzalez-Barca

Blood (2007) 110 (11): 4459.

https://doi.org/10.1182/blood.V110.11.4459.4459

Published: 2007

Journal Articles

Concomitant Intrathecal Liposomal Cytarabine and Prednisolone Is a Safe and Well Tolerated Treatment Option in Pediatric Leukemia and Neuroblastoma Patients.

Helga Björgvinsdóttir, Albert N. Bekassy, Jacek Toporski, Jesper Heldrup

Blood (2006) 108 (11): 5527.

https://doi.org/10.1182/blood.V108.11.5527.5527

Published: 2006

Journal Articles

Liposomal Cytarabine for Central Nervous System (CNS) Relapse in Acute Promyelocytic Leukemia (APL).

Carlo Castagnola, M. Lunghi, S. Calatroni, M. Lazzarino

Blood (2006) 108 (11): 4588.

https://doi.org/10.1182/blood.V108.11.4588.4588

Published: 2006

Journal Articles

Efficacy and Safety of DepoCyte® (Liposomal Cytarabine) in Patients with CNS Involvement from Non-Hodgkin’s Lymphoma (NHL): A Report on 32 Patients Treated in Spain.

José A. García-Marco, B. Navarro, E. Ruiz Sanz, L. Palomera, F.J. Capote, A. Fernández de Sevilla, E.G. Sánchez, A. Cantalapiedra, R. Pérez, J.R. Casal, J.D. Mediavilla, F.R. García, Y. Martín, C. Panizo, A.L. Alvarez, T. García, G. Pérez

Blood (2006) 108 (11): 2451.

https://doi.org/10.1182/blood.V108.11.2451.2451

Published: 2006

Journal Articles

Successful Treatment with Intrathecal (IT) Liposomal Cytarabine (Depocyte ® ) in a Refractory Meningeal Relapsed Child with T-ALL.

Rosanna Parasole, Giuseppe Menna, Argia Mangione, Luciano Marchese, Francesco Menna, Mimmo Ripaldi, Vincenzo Poggi

Blood (2005) 106 (11): 4575.

https://doi.org/10.1182/blood.V106.11.4575.4575

Published: 2005

NARROW

Acute Neurotoxicity during ALL Therapy Is Associated with Treatment Intensity, Age and Female Sex - an Analysis of SAE Reports from the UKALL 2003 Trial

Dose-Dense Chemoimmunotherapy Including Early CNS Prophylaxis for High-Risk DLBCL. -Final Analysis from a Nordic Phase II Study (the CHIC trial)

Incidence of Neurological Complications Secondary to Intrathecal Chemotherapy Used As Either Prophylaxis or Treatment of Leptomeningeal Carcinomatosis

Flow Cytometric Detection of Liposomes in the CSF of Patients with NHL/ALL, Treated with Intrathecal Liposomal Cytarabine: Synonymous of Toxicity?

Dose-Dense Chemoimmunotherapy and Early Central Nervous System Prophylaxis For High-Risk Diffuse Large B-Cell Lymphoma. –Preliminary Results From a Nordic Phase II Study

A Systematic Review on the Use of Intrathecal Rituximab in CNS Lymphoma

Liposomal Cytarabine (DepoCyte®) for the Prophylaxis and Treatment of Central Nervous System Involvement In Adult Acute Lymphoblastic Leukemia (ALL) - A Retrospective Analysis

Efficacy and Safety of Liposomal Cytarabine as Intrathecal Prophylaxis in Patients with Diffuse Large B Cell Lymphoma at High Risk of CNS Involvement: A Multicentric Study Including 80 Patients in Spain.

Intrathecal Liposomal Cytarabine (DepoCyte®) for Treatment of Leptomeningeal Involvement From Transformed (Richter's syndrome) and Non-Transformed B-Cell Chronic Lymphocytic Leukemia (B-CLL) in Spain: Report of 8 Cases.

Safety of Liposomal Cytarabine (DepoCyte ® ) in the Central Nervous System (CNS) Prophylaxis of Patients with Non-Hodgkin’s Lymphoma (NHL) and Acute Lymphoblastic Leukaemia: Results of a Single-Centre Experience

Safety of Intrathecal Liposomal Cytarabine (Depocyte®) Injection Given Prophylactically in Patients with High-Risk Diffuse Large B-Cell Lymphoma: A Report of 22 Patients in Spain.

Concomitant Intrathecal Liposomal Cytarabine and Prednisolone Is a Safe and Well Tolerated Treatment Option in Pediatric Leukemia and Neuroblastoma Patients.

Liposomal Cytarabine for Central Nervous System (CNS) Relapse in Acute Promyelocytic Leukemia (APL).

Efficacy and Safety of DepoCyte® (Liposomal Cytarabine) in Patients with CNS Involvement from Non-Hodgkin’s Lymphoma (NHL): A Report on 32 Patients Treated in Spain.

Successful Treatment with Intrathecal (IT) Liposomal Cytarabine (Depocyte ® ) in a Refractory Meningeal Relapsed Child with T-ALL.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only